To date, the mitotic count has remained the only proliferation criterion in the classification of lung neuroendocrine neoplasms in opposition to extra-pulmonary neuroendocrine tumors, which also rely on Ki-67 proliferation rate. The gene discussed is MKI67; the disease is lung neuroendocrine neoplasm.